Will pemetinib be included in medical insurance in 2025?

Pemigatinib, also known asPemigatinib, is an innovative targeted therapy drug mainly used to treat patients with cholangiocarcinoma carrying FGFR2 gene fusion or rearrangement. Cholangiocarcinoma is a highly aggressive malignant tumor with limited traditional treatments, and the emergence of pemetinib provides a new treatment option for these patients.

Pemetinib effectively blocks the proliferation and spread of cancer cells by inhibiting the activation of the FGFR2 signaling pathway. As a tyrosine kinase inhibitor, it can accurately act on tumor cells and reduce damage to normal cells. Clinical trials have shown that pemetinib has demonstrated significant efficacy in the treatment of cholangiocarcinoma, extending patients' survival and improving their quality of life.

However, pemetinib should be used with caution. Patients need to undergo genetic testing before taking it to confirm the presence of FGFR2 gene mutations or rearrangements. In addition, drugs may cause certain side effects, such as nausea, vomiting, diarrhea, fatigue, loss of appetite, etc. Patients need to pay close attention to their physical condition during use and communicate with their doctors in a timely manner. At the same time, doctors will also adjust the drug dosage or treatment plan in a timely manner based on the patient's specific condition and treatment response.

Pemetinib has been launched in the Chinese market, and patients can purchase the original version directly in domestic hospitals. Its specification is 4.5mg 14 tablets, and the market price is about 30,000 yuan. In foreign markets, both the original research version and the generic version are sold. The original research version of 13.5 mg 14 tablets is priced at about 72,000 yuan, while the generic version of Laos Lucius Pharmaceuticals is only about 850 yuan with the same specifications. If you want to learn more about pemetinib, it is recommended to consult a regular overseas medical service organization.

In general, pemetinib brings new treatment hope to patients with cholangiocarcinoma, but medical instructions must be followed during use to ensure the safety and effectiveness of the treatment.

xa0

Reference link: https://www.drugs.com/mtm/pemigatinib.html